Reproducibility of technetium-99m ethylenedicysteine clearance

European Journal of Nuclear Medicine

Volumn 26, Issue 8, 1999, Pages 900-902

  Kabasakal, Levent ^a   Halaç, Metin ^a   Alkan, Ebru ^a   Özçelik, Nihat ^a   Uslu, Ilhami ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Effective renal plasma flow; Radionuclide renography; Renal function; Technetium 99m ethylenedicysteine

Indexed keywords

CREATINE; CYSTEINE ETHYL ESTER TC 99M; TECHNETIUM 99M; UREA;

ACCURACY; ADULT; ARTICLE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; DRUG CLEARANCE; FEMALE; HUMAN; HUMAN CELL; KIDNEY AGENESIS; KIDNEY HYPOPLASIA; KIDNEY PLASMA FLOW; MALE; PLASMA CLEARANCE; RENOGRAPHY; SOLITARY KIDNEY; STATISTICAL ANALYSIS; UREA NITROGEN BLOOD LEVEL;

ADULT; CYSTEINE; FEMALE; HUMANS; KIDNEY; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; RADIOISOTOPE RENOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS;

EID: 0032788306     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050465     Document Type: Article

References (12)

1. 1. Verbruggen AM, Nosco DL, Nerom VCG, Bormans GM, Adrians PJ, De Roo MJ. Technetium-99m-L,L-ethylenedicysteine: a renal imaging agent. I. Labeling and evaluation in animals. J Nucl Med 1993; 20:738-746.
2. 99mTc-bicisate as a renal imaging agent. Nucl Med Commun 1997; 18:771-775.
3. 3. Kabasakal L, Turoǧlu HT, Önsel Ç, et al. Comparative continuous infusion renal clearance of Tc-99m-EC, Tc-99m-MAG3 and I-131-OIH in renal disorders. J Nucl Med 1995; 36: 224-228.
4. 4. Kabasakal L, Atay S, Vural AV, et al. Evaluation of technetium-99m-ethylenedicysteine in renal disorders and determination of extraction ratio. J Nucl Med 1995; 36:1398-1403.
5. 5. Uǧur Ö, Caner B, Çekirge S, Balkanci F, Ergün EL, Kostakoǧlu L, Bekdik C. The diagnosis of renovascular hypertension with technetium-99m-ethylenedicysteine captopril scintigraphy. Invest Radiol 1996; 31:378-381.
6. 99mTc-MAG3. Nucl Med Commun 1997; 18:44-52.
7. 7. Kabasakal L, Erdil TY, Ayaz M, et al. Evaluation of Tc-99m-EC in anuric hemodialysis patients. Eur J Nucl Med 1996; 23:1187.
8. 8. Kabasakal L, Yapar AF, Özker K, Alkan E, Atay S, Özçelik N, Önsel Ç. Simplified technetium-99m-EC clearance in adults from a single plasma sample. J Nucl Med 1997; 38:1784-1786.
9. 9. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986; II:307-310.
10. 10. Piepsz A, Tondeur M, Kinhaert J, Ham HR. Reproducibility of technetium-99m mercaptoacetyltriglycine clearance. Eur J Nucl Med 1996; 23:195-198.
11. 99mTc-MAG3 clearance under clinical conditions. Nucl Med Commun 1997:18; 352-357.
12. 12. Werner E, Blal C, Reiners C. Reproducibility of technetium-99m-MAG3 clearance using the Bubeck method. J Nucl Med 1998; 39:1066-1069.